Suchergebnisse - "Tachibana, Takayoshi"

PubPharm (178)

21

Dose-finding trial of azacitidine as post-transplant maintenance for high-risk MDS: a KSGCT prospective study

enthalten in: Annals of hematology | 2022

von Najima, Y. | Tachibana, T. | Takeda, Y. | +17

22

Impact of standard-dose dipeptidyl peptidase-4 inhibitors on the incidence of graft-versus-host disease among diabetes mellitus patients undergoing allogeneic hematopoietic cell transplantation: a KSGCT multicenter retrospective study

enthalten in: ResearchSquare.com | 2022

von Kanda, Y. | Kimura, S. | Shimizu, H. | +18

23

The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation

enthalten in: Hematological oncology | 2022

von Shimazu, Y. | Murata, M. | Kondo, T. | +17

24

Clinical impact of cigarette smoking on the outcomes of allogeneic hematopoietic stem cell transplantation : a multicenter retrospective study

enthalten in: Bone marrow transplantation | 2022

von Ohashi, T. | Aoki, J. | Ando, T. | +12

25

Allogeneic Hematopoietic Stem Cell Transplantation for Adult Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia in Second Complete Remission

enthalten in: Transplantation and cellular therapy | 2022

von Kaito, S. | Kurosawa, S. | Najima, Y. | +19

26

The Clinical Significance of BCR-ABL1 Mutations in Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation

enthalten in: Transplantation and cellular therapy | 2022

von Tachibana, T. | Kondo, T. | Uchida, N. | +11

27

Outcomes in patients with acute lymphoblastic leukemia who underwent second allogeneic hematopoietic cell transplantation for relapse after first transplantation

enthalten in: International journal of hematology | 2022

von Tachibana, T. | Tanaka, M. | Hagihara, M. | +3

28

Outcomes in patients with acute lymphoblastic leukemia who underwent second allogeneic hematopoietic cell transplantation for relapse after first transplantation

enthalten in: International journal of hematology | 2022

von Tachibana, T. | Tanaka, M. | Hagihara, M. | +3

29

A case series of patients treated with inotuzumab ozogamicin for acute lymphoblastic leukemia relapsed after allogeneic hematopoietic cell transplantation

enthalten in: International journal of hematology | 2022

von Izumi, A. | Tachibana, T. | Ando, T. | +3

30

The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation

enthalten in: Hematological Oncology | 2022

von Shimazu, Y. | Murata, M. | Kondo, T. | +16